Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TBX1
|
ENSG00000184058.8 | T-box transcription factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TBX1 | hg19_v2_chr22_+_19744226_19744226 | 0.29 | 1.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_31488433 | 4.82 |
ENST00000455608.1
|
SMTN
|
smoothelin |
chr2_-_31637560 | 4.00 |
ENST00000379416.3
|
XDH
|
xanthine dehydrogenase |
chrY_+_2709527 | 3.45 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr15_-_80263506 | 2.65 |
ENST00000335661.6
|
BCL2A1
|
BCL2-related protein A1 |
chr6_+_151662815 | 2.57 |
ENST00000359755.5
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chrY_+_2709906 | 2.47 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr9_+_139847347 | 2.36 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
chr1_-_153066998 | 2.32 |
ENST00000368750.3
|
SPRR2E
|
small proline-rich protein 2E |
chr19_-_51487282 | 2.25 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr1_-_153029980 | 2.09 |
ENST00000392653.2
|
SPRR2A
|
small proline-rich protein 2A |
chrY_+_15016725 | 2.08 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr10_+_97733786 | 2.04 |
ENST00000371198.2
|
CC2D2B
|
coiled-coil and C2 domain containing 2B |
chr11_+_18477369 | 2.03 |
ENST00000396213.3
ENST00000280706.2 |
LDHAL6A
|
lactate dehydrogenase A-like 6A |
chr5_-_59995921 | 2.03 |
ENST00000453022.2
ENST00000545085.1 ENST00000265036.5 |
DEPDC1B
|
DEP domain containing 1B |
chr2_-_169769787 | 2.02 |
ENST00000451987.1
|
SPC25
|
SPC25, NDC80 kinetochore complex component |
chr14_-_55658252 | 1.98 |
ENST00000395425.2
|
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr2_+_228678550 | 1.98 |
ENST00000409189.3
ENST00000358813.4 |
CCL20
|
chemokine (C-C motif) ligand 20 |
chr14_-_55658323 | 1.95 |
ENST00000554067.1
ENST00000247191.2 |
DLGAP5
|
discs, large (Drosophila) homolog-associated protein 5 |
chr1_-_161207953 | 1.87 |
ENST00000367982.4
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr1_-_153085984 | 1.75 |
ENST00000468739.1
|
SPRR2F
|
small proline-rich protein 2F |
chr22_+_42949925 | 1.71 |
ENST00000327678.5
ENST00000340239.4 ENST00000407614.4 ENST00000335879.5 |
SERHL2
|
serine hydrolase-like 2 |
chr7_-_105319536 | 1.68 |
ENST00000477775.1
|
ATXN7L1
|
ataxin 7-like 1 |
chr1_+_163291732 | 1.68 |
ENST00000271452.3
|
NUF2
|
NUF2, NDC80 kinetochore complex component |
chr5_+_137514687 | 1.68 |
ENST00000394894.3
|
KIF20A
|
kinesin family member 20A |
chr8_-_27457494 | 1.67 |
ENST00000521770.1
|
CLU
|
clusterin |
chr19_+_8429031 | 1.59 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
chr5_+_137514834 | 1.59 |
ENST00000508792.1
ENST00000504621.1 |
KIF20A
|
kinesin family member 20A |
chr1_-_153044083 | 1.53 |
ENST00000341611.2
|
SPRR2B
|
small proline-rich protein 2B |
chr20_+_37554955 | 1.45 |
ENST00000217429.4
|
FAM83D
|
family with sequence similarity 83, member D |
chr19_-_55652290 | 1.44 |
ENST00000589745.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr15_+_89922345 | 1.39 |
ENST00000558982.1
|
LINC00925
|
long intergenic non-protein coding RNA 925 |
chr14_-_91282726 | 1.38 |
ENST00000328459.6
ENST00000357056.2 |
TTC7B
|
tetratricopeptide repeat domain 7B |
chr6_+_151186554 | 1.35 |
ENST00000367321.3
ENST00000367307.4 |
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr7_+_143013198 | 1.34 |
ENST00000343257.2
|
CLCN1
|
chloride channel, voltage-sensitive 1 |
chr17_-_39203519 | 1.30 |
ENST00000542137.1
ENST00000391419.3 |
KRTAP2-1
|
keratin associated protein 2-1 |
chr14_-_98444461 | 1.29 |
ENST00000499006.2
|
C14orf64
|
chromosome 14 open reading frame 64 |
chr7_+_40174565 | 1.29 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
chrX_+_49216659 | 1.28 |
ENST00000415752.1
|
GAGE12I
|
G antigen 12I |
chr2_-_192016316 | 1.28 |
ENST00000358470.4
ENST00000432798.1 ENST00000450994.1 |
STAT4
|
signal transducer and activator of transcription 4 |
chr5_-_39270725 | 1.27 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
chr2_-_31440377 | 1.25 |
ENST00000444918.2
ENST00000403897.3 |
CAPN14
|
calpain 14 |
chr1_+_20915409 | 1.23 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
chr4_+_156680143 | 1.22 |
ENST00000505154.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr10_+_95256356 | 1.20 |
ENST00000371485.3
|
CEP55
|
centrosomal protein 55kDa |
chr2_-_113594279 | 1.20 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr16_-_30022293 | 1.19 |
ENST00000565273.1
ENST00000567332.2 ENST00000350119.4 |
DOC2A
|
double C2-like domains, alpha |
chr11_+_69924397 | 1.19 |
ENST00000355303.5
|
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr17_+_76210367 | 1.19 |
ENST00000592734.1
ENST00000587746.1 |
BIRC5
|
baculoviral IAP repeat containing 5 |
chr11_-_28129656 | 1.18 |
ENST00000263181.6
|
KIF18A
|
kinesin family member 18A |
chr20_-_54967187 | 1.18 |
ENST00000422322.1
ENST00000371356.2 ENST00000451915.1 ENST00000347343.2 ENST00000395911.1 ENST00000395907.1 ENST00000441357.1 ENST00000456249.1 ENST00000420474.1 ENST00000395909.4 ENST00000395914.1 ENST00000312783.6 ENST00000395915.3 ENST00000395913.3 |
AURKA
|
aurora kinase A |
chr2_-_241396106 | 1.17 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr5_+_150400124 | 1.17 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
chr22_-_37915535 | 1.16 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
chr11_+_47270436 | 1.15 |
ENST00000395397.3
ENST00000405576.1 |
NR1H3
|
nuclear receptor subfamily 1, group H, member 3 |
chr1_+_17531614 | 1.15 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
chr12_-_95942613 | 1.14 |
ENST00000393091.2
|
USP44
|
ubiquitin specific peptidase 44 |
chr6_-_160166218 | 1.13 |
ENST00000537657.1
|
SOD2
|
superoxide dismutase 2, mitochondrial |
chr4_+_156680518 | 1.12 |
ENST00000513437.1
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr21_+_30502806 | 1.12 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr12_+_93965609 | 1.12 |
ENST00000549887.1
ENST00000551556.1 |
SOCS2
|
suppressor of cytokine signaling 2 |
chr20_-_22565101 | 1.11 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
chr9_+_125137565 | 1.11 |
ENST00000373698.5
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
chr1_+_45205478 | 1.10 |
ENST00000452259.1
ENST00000372224.4 |
KIF2C
|
kinesin family member 2C |
chr1_-_182641367 | 1.10 |
ENST00000508450.1
|
RGS8
|
regulator of G-protein signaling 8 |
chr5_-_157002775 | 1.09 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr1_+_179561011 | 1.09 |
ENST00000294848.8
ENST00000444136.1 |
TDRD5
|
tudor domain containing 5 |
chr19_-_36001286 | 1.09 |
ENST00000602679.1
ENST00000492341.2 ENST00000472252.2 ENST00000602781.1 ENST00000402589.2 ENST00000458071.1 ENST00000436012.1 ENST00000443640.1 ENST00000450261.1 ENST00000467637.1 ENST00000480502.1 ENST00000474928.1 ENST00000414866.2 ENST00000392206.2 ENST00000488892.1 |
DMKN
|
dermokine |
chr11_-_2158507 | 1.08 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr14_+_23727694 | 1.07 |
ENST00000399905.1
ENST00000470456.1 |
C14orf164
|
chromosome 14 open reading frame 164 |
chr19_+_544034 | 1.03 |
ENST00000592501.1
ENST00000264553.3 |
GZMM
|
granzyme M (lymphocyte met-ase 1) |
chr8_+_66955648 | 1.02 |
ENST00000522619.1
|
DNAJC5B
|
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
chr14_+_58754751 | 1.01 |
ENST00000598233.1
|
AL132989.1
|
AL132989.1 |
chr17_+_80416050 | 0.96 |
ENST00000579198.1
ENST00000390006.4 ENST00000580296.1 |
NARF
|
nuclear prelamin A recognition factor |
chr22_-_37915247 | 0.96 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr1_+_15736359 | 0.96 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
chr11_+_15136462 | 0.96 |
ENST00000379556.3
ENST00000424273.1 |
INSC
|
inscuteable homolog (Drosophila) |
chr17_+_47296865 | 0.96 |
ENST00000573347.1
|
ABI3
|
ABI family, member 3 |
chr11_-_102826434 | 0.95 |
ENST00000340273.4
ENST00000260302.3 |
MMP13
|
matrix metallopeptidase 13 (collagenase 3) |
chr2_+_75061108 | 0.92 |
ENST00000290573.2
|
HK2
|
hexokinase 2 |
chr11_-_19262486 | 0.92 |
ENST00000250024.4
|
E2F8
|
E2F transcription factor 8 |
chr13_-_99404875 | 0.92 |
ENST00000376503.5
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1 |
chr1_+_153746683 | 0.92 |
ENST00000271857.2
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
chrX_-_15872914 | 0.91 |
ENST00000380291.1
ENST00000545766.1 ENST00000421527.2 ENST00000329235.2 |
AP1S2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr17_-_10741762 | 0.91 |
ENST00000580256.2
|
PIRT
|
phosphoinositide-interacting regulator of transient receptor potential channels |
chr17_+_76210267 | 0.91 |
ENST00000301633.4
ENST00000350051.3 ENST00000374948.2 ENST00000590449.1 |
BIRC5
|
baculoviral IAP repeat containing 5 |
chr20_+_44657845 | 0.90 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr8_+_1993173 | 0.89 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
chr16_+_640201 | 0.89 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
chr19_+_55014013 | 0.89 |
ENST00000301202.2
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2 |
chr19_-_48673580 | 0.88 |
ENST00000427526.2
|
LIG1
|
ligase I, DNA, ATP-dependent |
chr10_-_99771079 | 0.88 |
ENST00000309155.3
|
CRTAC1
|
cartilage acidic protein 1 |
chr6_-_40555176 | 0.87 |
ENST00000338305.6
|
LRFN2
|
leucine rich repeat and fibronectin type III domain containing 2 |
chr5_+_67088974 | 0.87 |
ENST00000513234.1
ENST00000504068.1 ENST00000515227.1 |
RP11-434D9.1
|
RP11-434D9.1 |
chr9_+_12693336 | 0.86 |
ENST00000381137.2
ENST00000388918.5 |
TYRP1
|
tyrosinase-related protein 1 |
chr3_+_26664291 | 0.86 |
ENST00000396641.2
|
LRRC3B
|
leucine rich repeat containing 3B |
chr8_-_62559366 | 0.86 |
ENST00000522919.1
|
ASPH
|
aspartate beta-hydroxylase |
chr19_-_15344243 | 0.86 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr1_+_28199047 | 0.85 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
chr19_-_42927251 | 0.85 |
ENST00000597001.1
|
LIPE
|
lipase, hormone-sensitive |
chr19_-_14016877 | 0.85 |
ENST00000454313.1
ENST00000591586.1 ENST00000346736.2 |
C19orf57
|
chromosome 19 open reading frame 57 |
chr19_-_17958771 | 0.84 |
ENST00000534444.1
|
JAK3
|
Janus kinase 3 |
chr14_-_24898731 | 0.83 |
ENST00000267406.6
|
CBLN3
|
cerebellin 3 precursor |
chr1_+_3689325 | 0.83 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
chrX_+_49363665 | 0.82 |
ENST00000381700.6
|
GAGE1
|
G antigen 1 |
chr19_+_46002868 | 0.82 |
ENST00000396735.2
|
PPM1N
|
protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative) |
chr19_+_45973120 | 0.82 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr16_-_2205352 | 0.82 |
ENST00000563192.1
|
RP11-304L19.5
|
RP11-304L19.5 |
chr2_+_85811525 | 0.82 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chr8_+_21899898 | 0.81 |
ENST00000518533.1
ENST00000359441.3 |
FGF17
|
fibroblast growth factor 17 |
chr17_-_34122596 | 0.80 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chrY_+_25130410 | 0.80 |
ENST00000331070.3
ENST00000382585.1 |
BPY2
|
basic charge, Y-linked, 2 |
chrY_+_26764151 | 0.80 |
ENST00000382392.1
|
BPY2B
|
basic charge, Y-linked, 2B |
chrY_-_27198251 | 0.80 |
ENST00000382287.1
|
BPY2C
|
basic charge, Y-linked, 2C |
chr4_-_90757364 | 0.80 |
ENST00000508895.1
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
chr4_+_156680153 | 0.80 |
ENST00000502959.1
ENST00000505764.1 ENST00000507146.1 ENST00000264424.8 ENST00000503520.1 |
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3 |
chr1_-_45308616 | 0.80 |
ENST00000447098.2
ENST00000372192.3 |
PTCH2
|
patched 2 |
chr9_+_77230499 | 0.80 |
ENST00000396204.2
|
RORB
|
RAR-related orphan receptor B |
chr7_+_134212312 | 0.80 |
ENST00000359579.4
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase) |
chr1_+_8378140 | 0.79 |
ENST00000377479.2
|
SLC45A1
|
solute carrier family 45, member 1 |
chr15_+_76016293 | 0.79 |
ENST00000332145.2
|
ODF3L1
|
outer dense fiber of sperm tails 3-like 1 |
chr10_+_94352956 | 0.79 |
ENST00000260731.3
|
KIF11
|
kinesin family member 11 |
chr20_-_35890211 | 0.79 |
ENST00000373614.2
|
GHRH
|
growth hormone releasing hormone |
chrX_-_133119476 | 0.78 |
ENST00000543339.1
|
GPC3
|
glypican 3 |
chrX_-_152939252 | 0.78 |
ENST00000340888.3
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr10_+_89419370 | 0.78 |
ENST00000361175.4
ENST00000456849.1 |
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr1_-_161207986 | 0.77 |
ENST00000506209.1
ENST00000367980.2 |
NR1I3
|
nuclear receptor subfamily 1, group I, member 3 |
chr12_-_48164812 | 0.77 |
ENST00000549151.1
ENST00000548919.1 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr6_-_86099898 | 0.76 |
ENST00000455071.1
|
RP11-30P6.6
|
RP11-30P6.6 |
chr19_-_43382142 | 0.76 |
ENST00000597058.1
|
PSG1
|
pregnancy specific beta-1-glycoprotein 1 |
chr6_+_54172653 | 0.76 |
ENST00000370869.3
|
TINAG
|
tubulointerstitial nephritis antigen |
chr8_+_38965048 | 0.76 |
ENST00000399831.3
ENST00000437682.2 ENST00000519315.1 ENST00000379907.4 ENST00000522506.1 |
ADAM32
|
ADAM metallopeptidase domain 32 |
chr3_+_160117418 | 0.76 |
ENST00000465903.1
ENST00000485645.1 ENST00000360111.2 ENST00000472991.1 ENST00000467468.1 ENST00000469762.1 ENST00000489573.1 ENST00000462787.1 ENST00000490207.1 ENST00000485867.1 |
SMC4
|
structural maintenance of chromosomes 4 |
chr17_+_39975455 | 0.75 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr9_+_36572851 | 0.75 |
ENST00000298048.2
ENST00000538311.1 ENST00000536987.1 ENST00000545008.1 ENST00000536860.1 ENST00000536329.1 ENST00000541717.1 ENST00000543751.1 |
MELK
|
maternal embryonic leucine zipper kinase |
chr16_+_68877496 | 0.74 |
ENST00000261778.1
|
TANGO6
|
transport and golgi organization 6 homolog (Drosophila) |
chr21_+_31768348 | 0.74 |
ENST00000355459.2
|
KRTAP13-1
|
keratin associated protein 13-1 |
chr17_-_39306054 | 0.74 |
ENST00000343246.4
|
KRTAP4-5
|
keratin associated protein 4-5 |
chr22_+_35776828 | 0.74 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
chr2_-_208490027 | 0.74 |
ENST00000458426.1
ENST00000406927.2 ENST00000425132.1 |
METTL21A
|
methyltransferase like 21A |
chr15_-_75017711 | 0.74 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
chr1_-_204135450 | 0.74 |
ENST00000272190.8
ENST00000367195.2 |
REN
|
renin |
chr12_+_102513950 | 0.73 |
ENST00000378128.3
ENST00000327680.2 ENST00000541394.1 ENST00000543784.1 |
PARPBP
|
PARP1 binding protein |
chr15_+_78857849 | 0.73 |
ENST00000299565.5
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
chr9_-_114362093 | 0.72 |
ENST00000538962.1
ENST00000407693.2 ENST00000238248.3 |
PTGR1
|
prostaglandin reductase 1 |
chr19_-_43702231 | 0.71 |
ENST00000597374.1
ENST00000599371.1 |
PSG4
|
pregnancy specific beta-1-glycoprotein 4 |
chr19_-_42916499 | 0.70 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase, hormone-sensitive |
chr12_+_1099675 | 0.70 |
ENST00000545318.2
|
ERC1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr7_+_139478030 | 0.70 |
ENST00000425687.1
ENST00000263552.6 ENST00000438104.1 ENST00000336425.5 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr19_-_36001113 | 0.70 |
ENST00000434389.1
|
DMKN
|
dermokine |
chr8_+_103563792 | 0.70 |
ENST00000285402.3
|
ODF1
|
outer dense fiber of sperm tails 1 |
chr19_-_2256405 | 0.70 |
ENST00000300961.6
|
JSRP1
|
junctional sarcoplasmic reticulum protein 1 |
chr13_+_109248500 | 0.70 |
ENST00000356711.2
|
MYO16
|
myosin XVI |
chr1_-_156786530 | 0.70 |
ENST00000368198.3
|
SH2D2A
|
SH2 domain containing 2A |
chr4_-_73434498 | 0.69 |
ENST00000286657.4
|
ADAMTS3
|
ADAM metallopeptidase with thrombospondin type 1 motif, 3 |
chr3_+_57094469 | 0.69 |
ENST00000334325.1
|
SPATA12
|
spermatogenesis associated 12 |
chr13_+_113548643 | 0.69 |
ENST00000375608.3
|
MCF2L
|
MCF.2 cell line derived transforming sequence-like |
chr2_+_204571375 | 0.69 |
ENST00000374478.4
|
CD28
|
CD28 molecule |
chr15_+_59397298 | 0.69 |
ENST00000559622.1
|
CCNB2
|
cyclin B2 |
chr19_+_21541732 | 0.69 |
ENST00000311015.3
|
ZNF738
|
zinc finger protein 738 |
chr17_+_39975544 | 0.68 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr10_-_98119030 | 0.68 |
ENST00000371172.3
ENST00000393871.1 ENST00000419479.1 |
OPALIN
|
oligodendrocytic myelin paranodal and inner loop protein |
chr1_-_156786634 | 0.68 |
ENST00000392306.2
ENST00000368199.3 |
SH2D2A
|
SH2 domain containing 2A |
chr1_+_17559776 | 0.68 |
ENST00000537499.1
ENST00000413717.2 ENST00000536552.1 |
PADI1
|
peptidyl arginine deiminase, type I |
chr15_+_41624892 | 0.68 |
ENST00000260359.6
ENST00000450318.1 ENST00000450592.2 ENST00000559596.1 ENST00000414849.2 ENST00000560747.1 ENST00000560177.1 |
NUSAP1
|
nucleolar and spindle associated protein 1 |
chr9_+_135937365 | 0.67 |
ENST00000372080.4
ENST00000351304.7 |
CEL
|
carboxyl ester lipase |
chr11_-_7818520 | 0.67 |
ENST00000329434.2
|
OR5P2
|
olfactory receptor, family 5, subfamily P, member 2 |
chr5_+_54320078 | 0.67 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr3_-_109056419 | 0.67 |
ENST00000335658.6
|
DPPA4
|
developmental pluripotency associated 4 |
chr4_-_8073705 | 0.67 |
ENST00000514025.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
chr5_-_145214893 | 0.67 |
ENST00000394450.2
|
PRELID2
|
PRELI domain containing 2 |
chr1_-_20446020 | 0.67 |
ENST00000375105.3
|
PLA2G2D
|
phospholipase A2, group IID |
chr1_-_230561475 | 0.66 |
ENST00000391860.1
|
PGBD5
|
piggyBac transposable element derived 5 |
chr19_+_10381769 | 0.66 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr15_+_81071684 | 0.66 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
chr21_-_31869451 | 0.66 |
ENST00000334058.2
|
KRTAP19-4
|
keratin associated protein 19-4 |
chr10_+_52152766 | 0.66 |
ENST00000596442.1
|
AC069547.2
|
Uncharacterized protein |
chr12_-_13529642 | 0.66 |
ENST00000318426.2
|
C12orf36
|
chromosome 12 open reading frame 36 |
chr3_+_160117087 | 0.65 |
ENST00000357388.3
|
SMC4
|
structural maintenance of chromosomes 4 |
chr19_+_45409011 | 0.65 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr1_-_114429997 | 0.65 |
ENST00000471267.1
ENST00000393320.3 |
BCL2L15
|
BCL2-like 15 |
chr6_-_28303901 | 0.65 |
ENST00000439158.1
ENST00000446474.1 ENST00000414431.1 ENST00000344279.6 ENST00000453745.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
chr3_-_57678772 | 0.65 |
ENST00000311128.5
|
DENND6A
|
DENN/MADD domain containing 6A |
chr3_-_126373929 | 0.64 |
ENST00000523403.1
ENST00000524230.2 |
TXNRD3
|
thioredoxin reductase 3 |
chr19_+_10397648 | 0.64 |
ENST00000340992.4
ENST00000393717.2 |
ICAM4
|
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
chr14_-_106963409 | 0.64 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr5_+_69321361 | 0.64 |
ENST00000515588.1
|
SERF1B
|
small EDRK-rich factor 1B (centromeric) |
chr18_+_45778672 | 0.64 |
ENST00000600091.1
|
AC091150.1
|
HCG1818186; Uncharacterized protein |
chr5_-_157002749 | 0.64 |
ENST00000517905.1
ENST00000430702.2 ENST00000394020.1 |
ADAM19
|
ADAM metallopeptidase domain 19 |
chrX_+_135251783 | 0.63 |
ENST00000394153.2
|
FHL1
|
four and a half LIM domains 1 |
chr15_+_85427879 | 0.63 |
ENST00000338602.2
ENST00000537216.1 ENST00000538177.1 ENST00000537624.1 |
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1 |
chr7_-_94953878 | 0.63 |
ENST00000222381.3
|
PON1
|
paraoxonase 1 |
chr19_-_46974664 | 0.63 |
ENST00000438932.2
|
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
chr5_-_10308125 | 0.63 |
ENST00000296658.3
|
CMBL
|
carboxymethylenebutenolidase homolog (Pseudomonas) |
chr1_+_202172848 | 0.63 |
ENST00000255432.7
|
LGR6
|
leucine-rich repeat containing G protein-coupled receptor 6 |
chr19_-_46974741 | 0.62 |
ENST00000313683.10
ENST00000602246.1 |
PNMAL1
|
paraneoplastic Ma antigen family-like 1 |
chr12_-_48152428 | 0.62 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr6_-_53213587 | 0.62 |
ENST00000542638.1
ENST00000370913.5 ENST00000541407.1 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
chr1_-_204121013 | 0.61 |
ENST00000367201.3
|
ETNK2
|
ethanolamine kinase 2 |
chr12_+_53443680 | 0.61 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr7_+_141811539 | 0.61 |
ENST00000550469.2
ENST00000477922.3 |
RP11-1220K2.2
|
Putative inactive maltase-glucoamylase-like protein LOC93432 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.6 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.7 | 2.0 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.7 | 3.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.6 | 1.7 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.5 | 2.1 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.5 | 1.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 1.3 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.4 | 1.3 | GO:0060557 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.4 | 1.2 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.4 | 3.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.4 | 2.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.4 | 1.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.4 | 1.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.3 | 1.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.3 | 1.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.3 | 1.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.3 | 0.9 | GO:0042938 | dipeptide transport(GO:0042938) |
0.3 | 1.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 0.9 | GO:0045210 | negative regulation of dendritic cell cytokine production(GO:0002731) FasL biosynthetic process(GO:0045210) |
0.3 | 1.7 | GO:1902847 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.3 | 1.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.3 | 0.8 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.3 | 1.3 | GO:2000470 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.3 | 0.8 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.3 | 0.8 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.2 | 0.7 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) negative regulation of mast cell cytokine production(GO:0032764) |
0.2 | 1.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.2 | 0.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.2 | 1.1 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:2000646 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.9 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.2 | 0.6 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.2 | 0.8 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 1.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.2 | 1.2 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 0.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 4.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.6 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 1.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.7 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.2 | 1.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.7 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 1.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.2 | 1.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.9 | GO:0042100 | B cell proliferation(GO:0042100) |
0.2 | 0.5 | GO:0018013 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.4 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.4 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.3 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
0.1 | 0.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.1 | 0.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.4 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 1.2 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.4 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.9 | GO:1901526 | negative regulation of mitochondrial membrane permeability(GO:0035795) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 0.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.4 | GO:0050894 | determination of affect(GO:0050894) |
0.1 | 3.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.4 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.1 | 0.6 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 1.3 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.6 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.1 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.4 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.7 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.1 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.5 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.1 | 0.6 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.3 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 1.0 | GO:0019216 | regulation of lipid metabolic process(GO:0019216) |
0.1 | 2.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.1 | 1.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 2.5 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 1.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.5 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 1.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 1.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 0.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 1.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.8 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.0 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.2 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 0.9 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.1 | 0.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 1.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 6.8 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 2.4 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.1 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.1 | 1.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 1.1 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.4 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.3 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.3 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.3 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.1 | 0.3 | GO:2000681 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.2 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.6 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.1 | 0.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 1.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 0.2 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.9 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.4 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.1 | 0.3 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.8 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.4 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.1 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.2 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.1 | 0.6 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.4 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.1 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.2 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 0.6 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 2.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 0.3 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 0.3 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.3 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.2 | GO:2000705 | dense core granule biogenesis(GO:0061110) positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.4 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.1 | 0.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.3 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.1 | 0.7 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.8 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.5 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.5 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.1 | 0.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.1 | 0.2 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.1 | 0.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.1 | 0.5 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.2 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.3 | GO:0070358 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.5 | GO:0042148 | strand invasion(GO:0042148) |
0.1 | 1.5 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.2 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 2.6 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 1.0 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 0.2 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.1 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
0.1 | 0.2 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.2 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.1 | 0.3 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.3 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.0 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.0 | 0.2 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.1 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.0 | 0.2 | GO:1902896 | terminal web assembly(GO:1902896) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.2 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.5 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.1 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.0 | 0.8 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 0.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.3 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.0 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.3 | GO:0044266 | angiotensin catabolic process in blood(GO:0002005) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
0.0 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.9 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.2 | GO:0048241 | epinephrine transport(GO:0048241) |
0.0 | 1.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.0 | 0.7 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.0 | 0.4 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
0.0 | 0.1 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.0 | 0.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:1903939 | negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of TORC2 signaling(GO:1903939) |
0.0 | 0.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.0 | 0.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.0 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.1 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.0 | 0.3 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.0 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.7 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.2 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
0.0 | 0.5 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.3 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.0 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.1 | GO:0031247 | actin rod assembly(GO:0031247) |
0.0 | 0.1 | GO:0098657 | import into cell(GO:0098657) import across plasma membrane(GO:0098739) |
0.0 | 0.2 | GO:1901355 | response to rapamycin(GO:1901355) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 1.4 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.7 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.4 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.0 | 1.2 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.5 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 2.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.2 | GO:0051944 | peptidyl-cysteine methylation(GO:0018125) positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 2.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 1.1 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.0 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.0 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.1 | GO:0072679 | thymocyte migration(GO:0072679) |
0.0 | 0.3 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.1 | GO:0051781 | positive regulation of cell division(GO:0051781) |
0.0 | 0.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.0 | 5.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.0 | 0.2 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.0 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.0 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.1 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.0 | 0.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 0.4 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.1 | GO:0048867 | ganglion mother cell fate determination(GO:0007402) stem cell fate determination(GO:0048867) |
0.0 | 0.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 1.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.0 | 0.1 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
0.0 | 3.9 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.2 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 1.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 5.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.0 | 0.4 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.0 | 0.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.0 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.0 | 0.3 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.0 | 0.0 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.0 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.1 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.1 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.4 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.2 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.0 | 0.3 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.0 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.4 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.4 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.6 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 1.0 | GO:0048538 | thymus development(GO:0048538) |
0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.8 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.2 | GO:0009595 | detection of biotic stimulus(GO:0009595) |
0.0 | 3.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 2.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.6 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.5 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.1 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.2 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.0 | 0.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.4 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 2.4 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0001675 | acrosome assembly(GO:0001675) |
0.0 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 0.1 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.3 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.3 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 0.0 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.3 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.0 | 0.1 | GO:1901898 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.0 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.3 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.2 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.0 | 0.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.0 | 0.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.3 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 2.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |